400-921-8278
| Catalog_no | ADMC0155 |
| Product_name | Duvelisib (IPI-145, INK1197) |
| Category | 抑制剂与激动剂 |
| Size | 10mg/50mg/100mg |
| Price | 1220.00/2660.00/4440.00 |
| Specificity | Target: PI3K. Fields: IPI-145 is an orally bioavailable, highly selective and potent small molecule inhibitor of the delta and gamma isoforms of phosphoinositide-3 kinase (PI3K) with potential immunomodulating and antineoplastic activities. IC50: 1 |
| Dilution | IC50: 1 nM (PI3K δ), 50 nM (PI3K γ) |
| Purification | >98% |
| Concentration | 靶点：PI3K;IC50： 1 nM (PI3K δ), 50 nM (PI3K γ) |
| Storage_stability | 2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername | IPI145; IPI 145; IPI-145. INK-1197; INK 1197; INK1197,Duvelisib (IPI-145, INK1197) |
| Observed_band | 416.86 |
| Notes | IPI-145 is an orally bioavailable, highly selective and potent small molecule inhibitor of the delta and gamma isoforms of phosphoinositide-3 kinase (PI3K) with potential immunomodulating and antineoplastic activities. IC50: 1 nM (PI3K δ), 50 nM (PI3 |
| Instructions | 
查看与下载 |
| Share |
 |
Copyright © 2021 苏州博特龙免疫技术有限公司 版权所有 ，苏ICP备2021013855号-1
苏公网安备32050702011981号 
